Evidence map›Paper›PMID 40609075›Full record

ArticleJournal of medical Internet research2025

E-Cigarette Narratives of User-Generated Posts on Xiaohongshu in China: Content Analysis.

Tingfen Ji, Zhao Liu, Zheng Su, Xin Xia, Yi Liu, Ying Xie, Zhenxiao Huang, Xinmei Zhou, Min Wang, Anqi Cheng and 10 more

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. What drives EBSA across contexts? evidence from China using BERTopic.Frontiers in child and adolescent psychiatry · 2026
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Tingfen Ji *China-Japan Friendship School of Clinical Medicine, Capital Medical University, Beijing, China.ORCID http://orcid.org/0000-0002-1245-8225
Zhao Liu *Department of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China, 86 010 8420 5288, 86 010-64217749.ORCID http://orcid.org/0000-0001-9529-3720
Zheng SuDepartment of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China, 86 010 8420 5288, 86 010-64217749.ORCID http://orcid.org/0000-0002-3266-3373
Xin XiaDepartment of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China, 86 010 8420 5288, 86 010-64217749.ORCID http://orcid.org/0009-0000-3101-2555
Yi LiuDepartment of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China, 86 010 8420 5288, 86 010-64217749.ORCID http://orcid.org/0009-0003-8033-4341
Ying XieDepartment of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China, 86 010 8420 5288, 86 010-64217749.ORCID http://orcid.org/0000-0002-7941-5772
Zhenxiao HuangDepartment of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China, 86 010 8420 5288, 86 010-64217749.ORCID http://orcid.org/0009-0008-7611-9071
Xinmei ZhouDepartment of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China, 86 010 8420 5288, 86 010-64217749.ORCID http://orcid.org/0000-0002-6775-8583
Min WangDepartment of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China, 86 010 8420 5288, 86 010-64217749.ORCID http://orcid.org/0009-0005-1155-1558
Anqi ChengDepartment of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China, 86 010 8420 5288, 86 010-64217749.ORCID http://orcid.org/0009-0000-4245-0315
Qingqing SongChina-Japan Friendship School of Clinical Medicine, Capital Medical University, Beijing, China.ORCID http://orcid.org/0000-0002-8027-1534
Yuxin ShiDepartment of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China, 86 010 8420 5288, 86 010-64217749.ORCID http://orcid.org/0009-0002-3060-8706
Shunyi ShiDepartment of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China, 86 010 8420 5288, 86 010-64217749.ORCID http://orcid.org/0009-0003-5786-0124
Aihemaiti AilifeireDepartment of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China, 86 010 8420 5288, 86 010-64217749.ORCID http://orcid.org/0009-0007-2404-2466
Jiahui HeChina-Japan Friendship School of Clinical Medicine, Capital Medical University, Beijing, China.ORCID http://orcid.org/0009-0002-2214-3507
Yingman GaoDepartment of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China, 86 010 8420 5288, 86 010-64217749.ORCID http://orcid.org/0009-0007-4235-851X
Liang ZhaoDepartment of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China, 86 010 8420 5288, 86 010-64217749.ORCID http://orcid.org/0009-0007-5366-4088
Liyan WuCentral Sterile Supply Department, WangJing Hospital of China Academy of Chinese Medical Sciences, Beijing, China.ORCID http://orcid.org/0009-0009-9723-4033
Dan XiaoDepartment of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China, 86 010 8420 5288, 86 010-64217749.ORCID http://orcid.org/0000-0002-3691-7852
Chen WangDepartment of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China, 86 010 8420 5288, 86 010-64217749.ORCID http://orcid.org/0000-0001-7857-5435

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Social media platforms have become influential spaces for disseminating information about electronic cigarettes (e-cigarettes). Concerns persist about the spread of misleading content, particularly among social media vulnerable groups. Xiaohongshu (RedNote), widely used by Chinese youth, plays a growing role in shaping e-cigarette perceptions. Understanding the narratives circulating on this platform is essential for identifying misinformation, assessing public perception, and guiding future health communication strategies. Objective: This study aimed to analyze the content, topics, user engagement, and sentiment trends of e-cigarette-related posts on Xiaohongshu and to assess the factors that influence engagement. Methods: E-cigarette-related posts published on Xiaohongshu between January 2020 and November 2024 were collected using web scraping, based on a predefined keyword list and a time-stratified random sampling strategy. Posts were categorized into 4 themes: advertising promotion, health hazards, usage interaction, and others. High-frequency keywords were extracted, and representative quotes were included to illustrate user perspectives across each category. Sentiment analysis was performed on posts in the usage interaction category to assess public attitudes. We defined 4 sentiment categories: positive, negative, neutral, and mixed. Logistic regression was conducted to explore the effects of post type, content length, and thematic classification on user engagement metrics such as likes, saves, and comments. Results: A total of 1729 posts were included and analyzed. Usage interaction posts were the most common (681/1729, 39.39%), with keywords such as "experience," "regulations," and "quit smoking" dominating this category. Advertising promotion posts (512/1729, 29.61%) frequently used terms like "flavor," "fashion," and "design" to attract younger users. Health hazards posts (311/1729, 17.99%) highlighted risks with keywords like "nicotine," "addiction," and "secondhand smoke," while others included policy and industry updates. Representative quotes highlighted typical concerns about aesthetics, health risks, and cessation struggles. Health hazards posts garnered the highest engagement in terms of likes and saves, despite their limited presence (odds ratio [OR] 1.498, 95% CI 1.099-2.042, P=.01). Video posts significantly outperformed text-image posts in generating comments (OR 2.624, 95% CI 2.017-3.439, P<.001). Sentiment analysis of the usage interaction posts (n=681) revealed that 53.45% (364/681) were positive, highlighting reduced harm, convenience, or flavor preferences. Negative sentiment was observed in 33.48% (228/681) of posts, often expressing concerns about addiction and health risks. Mixed sentiments appeared in 6.90% (47/681), acknowledging both pros and cons. In addition, 6.17% (42/681) of posts were classified as neutral without evident emotional tone. Conclusions: The findings underscore the dual role of Xiaohongshu as a platform for both e-cigarette promotion and public discourse. Misleading marketing targeting vulnerable groups, such as adolescents, remains a critical issue. However, the strong user response to health-related content suggests that social media platforms could be leveraged for effective health education. Strengthened regulatory oversight and educational campaigns leveraging engaging content formats are urgently needed to counter misinformation and protect public health.

Indexed as

Electronic Nicotine Delivery SystemsNarrationSocial MediaAdvertisingChinaHumansqualitative researchRedNotesocial mediateenagersvaping

Identifiers

PMID40609075
PMCPMC12244743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.